NorthWest Biotherapeutics Inc (NWBO)

[survivor1x]

"182 patients were ≥36 months past their surgery date; 44 of these (24.2%) have lived ≥36 months and these patients have KM-derived median survival estimate of 88.2 months"

Who else thinks that the 88.2 estimate will go up? I have a feeling once you get beyond 36 months of surgery without recurrence (Actual recurrence) the likelihood of recurrence is smaller than this initial estimate indicated. We may actually need to use another metric, patients can die from heart disease, stroke, COVID, auto accident.


What if we pushed that metric up to a median of 100 months? That would substantially increase the 5 year survival percentage.